RYCBX
Price
$65.52
Change
+$0.50 (+0.77%)
Updated
Oct 7 closing price
Net Assets
55.94M
RYUCX
Price
$74.53
Change
+$0.30 (+0.40%)
Updated
Oct 7 closing price
Net Assets
34.94M
Interact to see
Advertisement

RYCBX vs RYUCX

Header iconRYCBX vs RYUCX Comparison
Open Charts RYCBX vs RYUCXBanner chart's image
Rydex Inverse S&P 500 2x Strategy C
Price$65.52
Change+$0.50 (+0.77%)
VolumeN/A
Net Assets55.94M
Rydex Inverse S&P 500® Strategy C
Price$74.53
Change+$0.30 (+0.40%)
VolumeN/A
Net Assets34.94M
RYCBX vs RYUCX Comparison Chart in %
View a ticker or compare two or three
VS
RYCBX vs. RYUCX commentary
Oct 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYCBX is a Hold and RYUCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RYCBX has more cash in the bank: 55.9M vs. RYUCX (34.9M). RYCBX pays higher dividends than RYUCX: RYCBX (11.39) vs RYUCX (10.07). RYCBX was incepted earlier than RYUCX: RYCBX (25 years) vs RYUCX (25 years). RYCBX (2.60) and RYUCX (2.56) have similar cost to investors . RYCBX (2500) and RYUCX (2500) have matching initial minimum investment requirements. RYCBX (1000) and RYUCX (1000) have similar IRA initial investment minimum. RYUCX annual gain was more profitable for investors over the last year : -19.36 vs. RYCBX (-34.69). RYUCX return over 5 years is better than : -54.07 vs. RYCBX (-81.44).
RYCBXRYUCXRYCBX / RYUCX
Total Expense Ratio2.512.43103%
Annual Report Gross Expense Ratio2.602.56102%
Fund Existence25 years25 years-
Gain YTD-26.156-11.631225%
Front LoadN/AN/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRA10001000100%
Net Assets55.9M34.9M160%
Annual Yield % from dividends11.3910.07113%
Returns for 1 year-34.69-19.36179%
Returns for 3 years-72.45-44.95161%
Returns for 5 years-81.44-54.07151%
Returns for 10 years-96.83-79.58122%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OTLC0.100.02
+21.60%
Oncotelic Therapeutics, Inc.
SMSOF1.95N/A
N/A
SAMSONITE GROUP S A
TTHG0.12N/A
N/A
Titanium Holdings Group, Inc.
ZGXNF3.55N/A
N/A
Zigexn Co Ltd.
NTOIY9.39-0.12
-1.21%
Neste OYJ